Sign in
4

Changes in Ownership

IN8BIO, INC. Filed Acc 0001415889-25-003344

Options or other derivatives

  • Chief Operating Officer acquired 338,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rochlin Kate Chief Operating Officer 2025-02-05 Grant or award · Employee Stock Option (right to buy) +338,950 338,950 D
Loading xslF345X05/form4-02072025_040206.xml…